Tenon Medical CTO Richard Ginn Receives RSUs, Sells Shares

What Happened
Richard Ginn, Chief Technology Officer and director of Tenon Medical (TNON), had 126,577 restricted stock units (RSUs) convert into 126,577 common shares on July 31, 2026. A portion—44,809 shares—was sold on August 3, 2026 at $0.20 per share to cover the tax withholding, generating $8,872. The RSU conversion itself was recorded at $0.00 (no cash paid).

Key Details

• Transaction dates: RSU conversion (vest) on 2026-07-31; shares sold for tax withholding on 2026-08-03. Form 4 filed 2026-08-04 (appears timely).
• Prices/values: Conversion recorded at $0.00; sale of 44,809 shares at $0.20 each for $8,872 total.
• Shares after transactions: Filing details provided show 126,577 shares issued from RSUs and 44,809 sold for taxes, leaving roughly 81,768 shares from this grant (filing did not state total beneficial ownership across all holdings).
• Footnotes: F1 confirms conversion of 126,577 RSUs granted Oct 13, 2025; F2 indicates the sale was to pay tax liability; F3 clarifies 1 RSU = 1 share.
• Transaction codes: M = exercise/conversion of derivative (RSU vesting); F = tax withholding sale.

Context
This was an RSU vesting event with a routine tax-withholding sale (common when RSUs vest). Such sales to cover taxes are standard administrative actions and are not the same as an open-market sale signaling a change in sentiment. The cash proceeds involved here are modest (~$8.9k).